{"schema_version":"secwatch.filing_event.v1","accession":"0000950170-24-002685","form_type":"8-K","ticker":"AXSM","cik":"0001579428","company_name":"Axsome Therapeutics, Inc.","filed_at":"2024-01-08T23:59:59+00:00","discovered_at":"2026-05-14T18:03:24.686060+00:00","generated_at":"2026-06-07T02:17:25.813946+00:00","sec_items":["8.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.3,"calibrated_materiality_score":0.3,"confidence":"low","headline":"Axsome updates corporate presentation; no financial details disclosed in filing","bullets":["Axsome Therapeutics filed an 8-K on Jan 8, 2024, to announce an updated corporate presentation.","The presentation was posted to the company's website and filed as Exhibit 99.1.","No specific content, financial results, or guidance were provided in the filing.","Investors should refer to the full presentation on Axsome's website for details."],"urls":{"canonical":"https://secwatch.observer/filing/0000950170-24-002685","json":"https://secwatch.observer/filing/0000950170-24-002685.json","markdown":"https://secwatch.observer/filing/0000950170-24-002685.md","text":"https://secwatch.observer/filing/0000950170-24-002685.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1579428/000095017024002685/0000950170-24-002685-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1579428/000095017024002685/axsm-20240108.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-07T02:17:25.813946+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}